J. Garces

Reduction of immunosuppression for transplant-associated skin cancer: expert consensus survey.

Background  Reduction of immunosuppression is considered a reasonable adjuvant therapeutic strategy in solid‐organ transplant recipients experiencing multiple or high‐risk skin cancers. However, the literature provides no guidance about what threshold of cancer development would warrant initiation of reduction of immunosuppression.

Phaeohyphomycosis fungal infections in solid organ transplant recipients: clinical presentation, pathology, and treatment

Dematiaceous, or dark‐pigmented, fungi are known to cause infections such as phaeohyphomycosis, chromoblastomycosis, and mycetoma. These fungi are becoming increasingly important opportunistic pathogens in solid organ transplant recipients (SOTR). We present a retrospective chart review of 27 SOTR who developed phaeohyphomycosis infections post transplant from 1988 to 2009.

Calciphylaxis in Simultaneous Liver–Kidney Transplantation

We present four patients who underwent simultaneous liver–kidney transplantation (SLK) and were diagnosed with calciphylaxis, also known as calcific uremic arteriolopathy (CUA). Common characteristics included high MELD scores (mean 35.2 ± 4.8) and advanced renal disease (duration range 6–44 weeks). CUA was diagnosed within the first 2 months post‐SLK based on clinical features. Severe morbidity and prolonged hospital stay were observed and one of the patients died secondary to sepsis. Treatment included metabolic support, wound care, calcium level correction and use of sodium thiosulphate. CUA should be considered in the presence of painful dermatologic changes in patients status post SLK.